Introduction
The American Cancer Society estimates in 2014 more than 1.6 million Americans will be diagnosed with cancer and almost 600, 000 will die 1 . This excludes Americans with basal and squamous cell skin cancers. Almost 14 million people were alive after a diagnosis of cancer on January 1, 2012 1 . Therefore, every health care provider should be aware of the signs and symptoms of oncologic urgencies 2 Oncologic Emergencies and Urgencies 11 February 2015 and emergencies and initial management.
Any of these conditions can occur at any point in the course of illness. It is particularly important to remember that one of these conditions may be the first clinical evidence of an undiagnosed cancer.
Oncologic Emergencies

Spinal Cord Compression (SCC) and Cauda Equina Syndrome
Presentation SCC typically is a syndrome with a long prodrome, which is back pain. If the symptom is not attended to, it will predictably progress to paralysis. The pain can be localized in the central back, or may radiate out laterally on one or both sides (unilaterally or bilaterally). A change in the nature or severity of pre-existing back pain in a patient known to have a malignancy should be considered a warning sign.
Often, patients will report that they have had progressive pain over the preceding two weeks by the time they are paralyzed. However, patients with SCC may present with chronic back pain. Because back pain is such a common presenting complaint, it is appropriate to consider obtaining radiographic studies on patients with back pain accompanied by a neurologic deficit. When SCC is suspected, plain radiographs and bone scans are not definitive; the patient should go directly to spine MRI (Figure 1 ). If the condition is diagnosed and treated before paralysis sets in, patients may continue to walk. Once motor paralysis and particularly once autonomic dysfunction sets in, the process is almost always irreversible. Autonomic dysfunction initially causes constipation and urinary retention, but will progress to incontinence of urine and stool.
This catastrophic outcome is a reason that spinal cord compression is considered a true medical emergency.
Cauda Equina Syndrome
Compression of the cauda equina, which is below L1 in most adults, causes identical signs and symptoms, has the same etiology and is managed identically to SCC. It is referred to as cauda equina syndrome.
Mechanism & Etiology
Etiology
Compression of the spinal cord or cauda occurs when:
• Tumor within a vertebra grows into the spinal canal or a pathologic fracture drives bone fragments into the cord.
• Paraspinal tumor grows through the vertebral openings into the epidural foramen. • Metastatic tumor grows through the epidural space and impinges on the dura. Pain from an epidural lesion is usually in a dermatome distribution. Figure 2a . A 64 yo male presents with severe acute onset neck pain with both upper and lower extremity weakness and numbness. Coronal CT reformat demonstrates lytic metastasis to the left occipial condyle and right lateral mass of C1. Weaking of the bone has resulted in a pathologic fracture of the right lateral mass of C1 with loss of vertebral height. On further workup, a lung mass was identified and biopsy returned non-small cell lung cancer. Figure 2b is provided as comparison of normal anatomy. unstable pathologic fracture of the C4 vertebral body. Figure 3b from an intraoperative radiograph shows that this lesion has essentially replaced the vertebral body. Figure 3c is a postoperative radiograph after placement of an interbody spacer in the cavity created by removing the tumor. An anterior plate with anterior fixation screws span C3-C5 stabilizes these levels. Treatment involves pericardiocentesis and may require creation of a pericardial window.
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Uncal Herniation
The brain is confined in the rigid skull. As a result, additional tissue or swelling in the brain can increase intracranial pressure. Either primary brain cancers or metastases in the brain can cause brain tissue to press into the base of the skull and protrude through the foramen magnum. Temporal lobe pressure can transmit laterally and force the uncus, which contains the respiratory drive center, into the foramen magnum. The patient will have impaired brainstem function, Occasionally tumors within the central nervous system may bleed into themselves, presenting as a cerebrovascular accident.
Mechanism
The most common physiology is bleeding from friable, abnormal tumor vasculature. But on rare occasions, a tumor may invade through a blood vessel wall. If the affected vessel is a major artery, the bleeding may be massive and rapidly fatal. On the other hand, if the affected vessel is a minor vein, the bleeding may look just like bleeding from abnormal tumor vessels.
Treatment
The treatment of tumor bleeding depends on the location of the tumor and the anatomy of the normal structures surrounding it.
Volume replacement support and consideration of transfusion is the first step. It may be possible for an interventional radiologist to block the feeding vessels, provided that would not damage vital surrounding tissue. Similarly surgical ligation of these feeding vessels would stop the bleeding. If it is possible to resect the tumor, that would be the most rapid intervention. For chemo-sensitive tumors, chemotherapy may work.
Most commonly radiation therapy is used. For brain lesions, it is usually the only option. For tumors elsewhere in the body, it is usually the most cost effective and least invasive treatment available.
With conventional fractionation bleeding usually takes about two weeks to stop (and it almost always does stop). However, a single large radiotherapy dose will usually work much more rapidly.
Unfortunately such a large fraction may make it difficult to deliver 
Diagnosis
If there is concern that a patient may have a deep vein thrombosis in the pelvis or a lower extremity, Doppler ultrasound ( 
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Respiratory Compromise
Etiology Malignancy can cause respiratory distress through three primary mechanisms (Table 4 ). While most of the time, respiratory compromise is a medical emergency, for oncologists, after initial stabilization, it is only urgent. The reason for this statement is that, if the patient is in severe distress, intubation and ventilation is required.
Once that is accomplished and the airway is secure, there is time for whatever treatment required to be delivered. On the other hand, if this cannot be accomplished or is ineffective, the patient is usually beyond help. One exception would be an exquisitely sensitive tumor, which will respond rapidly to radiotherapy or chemotherapy. A second exception would be a situation where bronchoscopic suction or a laser resection will relieve the obstruction. Airways may be blocked in three ways. The most common cause of blockage is a mucous plug, which can be mechanically dislodged. 
Presentation
The patients tend to present tripoding and sitting bolt upright, with a history of sleeping in a chair for a few days. They are laboring to breathe with severe dyspnea at rest. If the tumor is in the upper airway, the presentation may be dominated by stridor. Once intubated, or once they have undergone tracheotomy, they reoxygenate rapidly, unless the blockage is distal to the tip of the endotracheal tube.
Management
If the problem is caused by a mucous plug, then suction may relieve the symptoms. If the issue is intrinsic compression, and the bronchoscope can be passed through the stenosis, laser may be used to unblock the tube, and/or perhaps a stent may be placed. But then the tumor must be treated, or it will often rapidly re-grow and re- obstruct. Extrinsic compression may, in unusual circumstances, be amenable to a stent. Usually the symptom will only respond to a treatment which actually shrinks the tumor, either chemotherapy or more usually, radiotherapy. Intrinsic obstruction may be amenable to endoluminal brachytherapy; but the dose from this procedure will not reach out to effectively treat a tumor causing extrinsic compression.
Patients with stridor and upper airway blockage can be readily treated by tracheotomy, and any physician may find it necessary to perform this lifesaving procedure. (Figure 6 ). If the tumor compressing the trachea is in the low anterior neck, for example anaplastic cancer of the thyroid, attempting tracheotomy is extremely dangerous. Cutting through the tumor can cause significant bleeding, and may then allow the tumor to grow down into the trachea. In this circumstance, even biopsy may be dangerous, and tracheotomy should not be attempted. Figure 6 . A 39 yo male with a rapidly enlarging mass in the right neck over a one month period presents with severe shortness of breath. Figure 5a is from a CT of the neck at presentation showing a large mass in the right neck with marked encroachment on the upper airway. This patient required an urgent tracheostomy as shown on Figure 6b should be biopsied. In the past, there was concern that elevated venous pressure from the mass would increase the risks associated with biopsies. Reviews of mediastinal mass biopsies in patients with superior vena cava syndrome have not shown an increased risk of complications compared with similar biopsies done in patients without the syndrome.
Once a diagnosis is made, treatment should be directed at the underlying cancer. If the tumor is an untreated lymphoma or leukemia, chemotherapy has an excellent chance of providing Return to beginning of chapter
Brain Metastases
Brain metastases are a relatively frequent complication of cancer; the annual incidence is almost 200,000 cases in the United States.
About half of these cases arise from lung cancer; breast cancer is the next most common site of origin and melanoma is the third common malignancy. There is a concept called the fertile field; metastases from certain cancers tend to spread to particular organs, and the brain is particularly affected by metastases from lung, breast and melanoma. Any cancer can give rise to brain metastases and today, as patients are living longer with cancer, more patients are presenting with brain lesions from previously unusual primary sites.
Once brain metastases are discovered, life expectancy is typically measured in months, and uncontrolled lesions can cause rapid neurologic deterioration. After treatment, patients whose extra-cranial disease is controlled will do better than those whose disease is not, and good performance status patients will live longer than poor performance status patients.
Presentation
Patients with brain metastases tend to present with symptoms of increased intracranial pressure, (headache, nausea and possibly vomiting), mental status changes, focal motor weakness, visual field cuts, papilledema, symptoms of a cerebral vascular accident or seizure. While the initial workup in an emergency room almost always includes a CT scan (Figure 8) , an MRI of the brain with gadolinium (Figure 9 .) provides far more information as to the extent of disease. Definitive treatment decisions virtually require that an 
Management
Initial management of brain metastasis is dexamethasone. This steroid decreases the peri-tumoral edema, thereby decreasing the intracranial pressure and mass effect. The patient's neurologic status will often improve rapidly after the initial administration of dexamethasone. Sometimes mannitol may be required to further decrease the intracranial pressure (ICP).
Patients who have presented with a seizure require effective anticonvulsant therapy. In the past, such therapy was initiated prophylactically to prevent seizures. This practice has been discouraged recently in patients who do not present with seizures.
Randomized trials of prophylactic anticonvulsants in patients with brain metastases showed no reduction in the risk of developing seizures. Hence, prophylactic anticonvulsants provide no benefit and merely expose patients needlessly to side effects of the drugs.
Nonetheless patients with brain metastases are at risk of sudden neurologic deterioration due to CVA, nausea or seizure. It is important that all such patients are instructed to stop driving, at least until their neurologic situation is clear and stable.
In patients for whom brain metastases are the presenting sign of malignancy, a search for a primary cancer is in order. This should not delay the start of treatment to the brain. If there is no preexisting diagnosis of malignancy, a biopsy is performed. Occasionally evidence of increased intracranial pressure or adverse medical condition may preclude this.
Today, management of brain metastases is a multi-disciplinary effort.
Traditionally, surgery was restricted to biopsy of previously undiagnosed cancers presenting with brain metastases or sometimes proving metastatic status if the brain lesion is the first known metastasis. Sometimes this biopsy would take the form of a resection of the lesion. However, the mainstay of treatment was palliative whole brain radiotherapy. The traditional palliative dose of radiation is radiobiologically insufficient to control bulk tumor deposits long term; it was adequate only because of the patient's short life expectancy.
For limited numbers of metastases (usually four or less), metastectomy or radiosurgery offers a chance of long-term control of the individual lesions. Which of these treatments is more effective
has not yet been demonstrated. The role of post-operative or post radiosurgery whole brain radiotherapy is not yet clear. It does not extend survival, but does decrease the incidence of further brain metastases, and this appears to enhance quality of life, although it has also been demonstrated to impact memory. Whole brain radiation may be used prior to radiosurgery in selected patients. 
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Carcinomatous Meningitis
Carcinomatous
Management
Initial management involves steroid therapy as for brain metastases.
The patient must be assessed for increased intracranial pressure, as a lumbar puncture (spinal tap) to obtain cells to confirm diagnosis and injection of intrathecal chemotherapy is the next step.
Radiotherapy to the whole brain, the base of the skull and the posterior half of the orbits, to encompass the entire outpouchings of the meninges around the cranial nerves is used to treat the cranial component of carcinomatous meningitis, since intrathecal chemotherapy is unlikely to effectively reach the outpouchings of the meninges around the cranial nerves . When intrathecal chemotherapy is utilized, it can be injected through a lumbar puncture. However, often an Ommaya reservoir is placed under the scalp, with a catheter extending into the lateral ventricle to deliver the therapy less traumatically and more effectively.
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Conclusion
Every clinician must understand oncologic emergencies and
